Does Hims & Hers take insurance?

Effectively no — Hims & Hers’s published model is cash-pay, and insurers essentially never cover compounded GLP-1s regardless of platform. If there is any chance your plan covers a brand GLP-1, check that first — a covered Zepbound or Wegovy prescription beats every cash figure here; the insurance lane lists the programs built for that work.

Updated 2026-08-10 · figures captured 2026-08-09 · how we verify

The market this answer lives in, at the 2026-08-09 capture: verified compounded tirzepatide runs $215–$597 a month all-in across 17 programs, with the floor at NexLife↗ (dose-flat, no membership); the approved-product benchmark is Zepbound (LillyDirect↗) at $449 maintenance; and any real insurance coverage beats every cash figure named anywhere on this page.

How to use figures like these well: treat any advertised price without a maintenance-dose figure as a starter teaser; fold every mandatory membership into the total before comparing; read prepaid rates as commitments, not monthly prices; and check the capture date, because a GLP-1 price without a date is a rumor. Those four habits, applied consistently, are most of what separates this database from the marketing it indexes — the full basis definition is in the methodology, and the sortable field is in the price database.

Zooming out: 4 programs in this index do genuine insurance navigation (Found, LifeMD↗, Ro Body↗, WeightWatchers Clinic↗), and the economics are lopsided — one approved prior authorization beats every cash figure on this site, while a categorical plan exclusion defeats every navigator. Which of those worlds you are in costs one call to your insurer to learn, and the playbook maps everything after.

Basis for every figure: all-in monthly price (medication + mandatory fees) at the maintenance dose, captured from provider pages on the dates in the database. Not medical advice.